The activation of the IRS1/SREBP-1 axis by miR-21 contributes to PCa advancement, suggesting that targeting the miR-21/SREBP-1 signaling pathway could be a promising approach to managing PCa aggressiveness (Kanagasabai et al., 2022). The gene discussed is IRS1; the disease is posterior cortical atrophy.